Q2 2021 Alterity Therapeutics Ltd Earnings Call Transcript
Good morning, and welcome to the Alterity Therapeutics H1 Financial Results and Business update. (Operator Instructions)
Today's call is being recorded. And I'd like to introduce you to our host, Dr. David Stamler, Alterity Therapeutics Chief Executive Officer. He is joined by Mr. Geoffrey Kempler, Founder and Chairman; and Ms. Kathryn Andrews, the company's Chief Financial Officer.
Over to you, Dr. Stamler.
Well, thank you, Greg. Good morning to our investors in Australia, and good afternoon to our investors here in the United States. Thank you for joining our call to discuss the first half year financial results and, more importantly, as a development stage company, our progress during the 6 months through December 2020 and during the first 2 months of this year.
Before turning to those topics, I'd like to first provide a little background on myself as I was appointed to the role of Chief Executive Officer in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
